Wearable Tech and Weight-Loss Drugs Offer New Hope
Two new significant studies from the University of Oxford, supported by Oxford Health Biomedical Research Centre (OH BRC) highlight this evolving landscape.
One study, featured in National Geographic*, explores the unexpected cognitive benefits of GLP-1 agonists—drugs originally developed for diabetes
